1 Study Coverage
1.1 Gene Therapies for Tumor Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Gene Therapies for Tumor Treatment Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Gene Induced Immunotherapy
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.3 Market by Application
1.3.1 Global Gene Therapies for Tumor Treatment Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Gene Therapies for Tumor Treatment Production
2.1 Global Gene Therapies for Tumor Treatment Production Capacity (2017-2028)
2.2 Global Gene Therapies for Tumor Treatment Production by Region: 2017 VS 2021 VS 2028
2.3 Global Gene Therapies for Tumor Treatment Production by Region
2.3.1 Global Gene Therapies for Tumor Treatment Historic Production by Region (2017-2022)
2.3.2 Global Gene Therapies for Tumor Treatment Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Gene Therapies for Tumor Treatment Sales in Volume & Value Estimates and Forecasts
3.1 Global Gene Therapies for Tumor Treatment Sales Estimates and Forecasts 2017-2028
3.2 Global Gene Therapies for Tumor Treatment Revenue Estimates and Forecasts 2017-2028
3.3 Global Gene Therapies for Tumor Treatment Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Gene Therapies for Tumor Treatment Sales by Region
3.4.1 Global Gene Therapies for Tumor Treatment Sales by Region (2017-2022)
3.4.2 Global Sales Gene Therapies for Tumor Treatment by Region (2023-2028)
3.5 Global Gene Therapies for Tumor Treatment Revenue by Region
3.5.1 Global Gene Therapies for Tumor Treatment Revenue by Region (2017-2022)
3.5.2 Global Gene Therapies for Tumor Treatment Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Gene Therapies for Tumor Treatment Production Capacity by Manufacturers
4.2 Global Gene Therapies for Tumor Treatment Sales by Manufacturers
4.2.1 Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2017-2022)
4.2.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Gene Therapies for Tumor Treatment in 2021
4.3 Global Gene Therapies for Tumor Treatment Revenue by Manufacturers
4.3.1 Global Gene Therapies for Tumor Treatment Revenue by Manufacturers (2017-2022)
4.3.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2021
4.4 Global Gene Therapies for Tumor Treatment Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Gene Therapies for Tumor Treatment Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Gene Therapies for Tumor Treatment Sales by Type
5.1.1 Global Gene Therapies for Tumor Treatment Historical Sales by Type (2017-2022)
5.1.2 Global Gene Therapies for Tumor Treatment Forecasted Sales by Type (2023-2028)
5.1.3 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
5.2 Global Gene Therapies for Tumor Treatment Revenue by Type
5.2.1 Global Gene Therapies for Tumor Treatment Historical Revenue by Type (2017-2022)
5.2.2 Global Gene Therapies for Tumor Treatment Forecasted Revenue by Type (2023-2028)
5.2.3 Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
5.3 Global Gene Therapies for Tumor Treatment Price by Type
5.3.1 Global Gene Therapies for Tumor Treatment Price by Type (2017-2022)
5.3.2 Global Gene Therapies for Tumor Treatment Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Gene Therapies for Tumor Treatment Sales by Application
6.1.1 Global Gene Therapies for Tumor Treatment Historical Sales by Application (2017-2022)
6.1.2 Global Gene Therapies for Tumor Treatment Forecasted Sales by Application (2023-2028)
6.1.3 Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
6.2 Global Gene Therapies for Tumor Treatment Revenue by Application
6.2.1 Global Gene Therapies for Tumor Treatment Historical Revenue by Application (2017-2022)
6.2.2 Global Gene Therapies for Tumor Treatment Forecasted Revenue by Application (2023-2028)
6.2.3 Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
6.3 Global Gene Therapies for Tumor Treatment Price by Application
6.3.1 Global Gene Therapies for Tumor Treatment Price by Application (2017-2022)
6.3.2 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2023-2028)
7 North America
7.1 North America Gene Therapies for Tumor Treatment Market Size by Type
7.1.1 North America Gene Therapies for Tumor Treatment Sales by Type (2017-2028)
7.1.2 North America Gene Therapies for Tumor Treatment Revenue by Type (2017-2028)
7.2 North America Gene Therapies for Tumor Treatment Market Size by Application
7.2.1 North America Gene Therapies for Tumor Treatment Sales by Application (2017-2028)
7.2.2 North America Gene Therapies for Tumor Treatment Revenue by Application (2017-2028)
7.3 North America Gene Therapies for Tumor Treatment Sales by Country
7.3.1 North America Gene Therapies for Tumor Treatment Sales by Country (2017-2028)
7.3.2 North America Gene Therapies for Tumor Treatment Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Gene Therapies for Tumor Treatment Market Size by Type
8.1.1 Europe Gene Therapies for Tumor Treatment Sales by Type (2017-2028)
8.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Type (2017-2028)
8.2 Europe Gene Therapies for Tumor Treatment Market Size by Application
8.2.1 Europe Gene Therapies for Tumor Treatment Sales by Application (2017-2028)
8.2.2 Europe Gene Therapies for Tumor Treatment Revenue by Application (2017-2028)
8.3 Europe Gene Therapies for Tumor Treatment Sales by Country
8.3.1 Europe Gene Therapies for Tumor Treatment Sales by Country (2017-2028)
8.3.2 Europe Gene Therapies for Tumor Treatment Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gene Therapies for Tumor Treatment Market Size by Type
9.1.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2017-2028)
9.1.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Type (2017-2028)
9.2 Asia Pacific Gene Therapies for Tumor Treatment Market Size by Application
9.2.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2017-2028)
9.2.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Application (2017-2028)
9.3 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
9.3.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2017-2028)
9.3.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Gene Therapies for Tumor Treatment Market Size by Type
10.1.1 Latin America Gene Therapies for Tumor Treatment Sales by Type (2017-2028)
10.1.2 Latin America Gene Therapies for Tumor Treatment Revenue by Type (2017-2028)
10.2 Latin America Gene Therapies for Tumor Treatment Market Size by Application
10.2.1 Latin America Gene Therapies for Tumor Treatment Sales by Application (2017-2028)
10.2.2 Latin America Gene Therapies for Tumor Treatment Revenue by Application (2017-2028)
10.3 Latin America Gene Therapies for Tumor Treatment Sales by Country
10.3.1 Latin America Gene Therapies for Tumor Treatment Sales by Country (2017-2028)
10.3.2 Latin America Gene Therapies for Tumor Treatment Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gene Therapies for Tumor Treatment Market Size by Type
11.1.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2017-2028)
11.1.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Type (2017-2028)
11.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Size by Application
11.2.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2017-2028)
11.2.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Application (2017-2028)
11.3 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country
11.3.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2017-2028)
11.3.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Overview
12.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Novartis Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Novartis Recent Developments
12.2 Kite Pharma
12.2.1 Kite Pharma Corporation Information
12.2.2 Kite Pharma Overview
12.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Kite Pharma Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Kite Pharma Recent Developments
12.3 Amgen
12.3.1 Amgen Corporation Information
12.3.2 Amgen Overview
12.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Amgen Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Amgen Recent Developments
12.4 Shanghai Sunway
12.4.1 Shanghai Sunway Corporation Information
12.4.2 Shanghai Sunway Overview
12.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shanghai Sunway Recent Developments
12.5 Sibiono
12.5.1 Sibiono Corporation Information
12.5.2 Sibiono Overview
12.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Sibiono Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Sibiono Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Gene Therapies for Tumor Treatment Industry Chain Analysis
13.2 Gene Therapies for Tumor Treatment Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Gene Therapies for Tumor Treatment Production Mode & Process
13.4 Gene Therapies for Tumor Treatment Sales and Marketing
13.4.1 Gene Therapies for Tumor Treatment Sales Channels
13.4.2 Gene Therapies for Tumor Treatment Distributors
13.5 Gene Therapies for Tumor Treatment Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Gene Therapies for Tumor Treatment Industry Trends
14.2 Gene Therapies for Tumor Treatment Market Drivers
14.3 Gene Therapies for Tumor Treatment Market Challenges
14.4 Gene Therapies for Tumor Treatment Market Restraints
15 Key Finding in The Global Gene Therapies for Tumor Treatment Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Gene Induced Immunotherapy
Table 3. Major Manufacturers of Oncolytic Virotherapy
Table 4. Major Manufacturers of Gene Transfer
Table 5. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Gene Therapies for Tumor Treatment Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 7. Global Gene Therapies for Tumor Treatment Production by Region (2017-2022) & (K Units)
Table 8. Global Gene Therapies for Tumor Treatment Production Market Share by Region (2017-2022)
Table 9. Global Gene Therapies for Tumor Treatment Production by Region (2023-2028) & (K Units)
Table 10. Global Gene Therapies for Tumor Treatment Production Market Share by Region (2023-2028)
Table 11. Global Gene Therapies for Tumor Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Gene Therapies for Tumor Treatment Sales by Region (2017-2022) & (K Units)
Table 13. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2017-2022)
Table 14. Global Gene Therapies for Tumor Treatment Sales by Region (2023-2028) & (K Units)
Table 15. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2023-2028)
Table 16. Global Gene Therapies for Tumor Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2017-2022)
Table 18. Global Gene Therapies for Tumor Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2023-2028)
Table 20. Global Gene Therapies for Tumor Treatment Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 21. Global Gene Therapies for Tumor Treatment Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 23. Global Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Gene Therapies for Tumor Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2017-2022)
Table 26. Gene Therapies for Tumor Treatment Price by Manufacturers 2017-2022 (USD/Unit)
Table 27. Global Gene Therapies for Tumor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Gene Therapies for Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2021)
Table 29. Gene Therapies for Tumor Treatment Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Gene Therapies for Tumor Treatment Product Offered
Table 31. Date of Manufacturers Enter into Gene Therapies for Tumor Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 34. Global Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 35. Global Gene Therapies for Tumor Treatment Sales Share by Type (2017-2022)
Table 36. Global Gene Therapies for Tumor Treatment Sales Share by Type (2023-2028)
Table 37. Global Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2017-2022)
Table 40. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2023-2028)
Table 41. Gene Therapies for Tumor Treatment Price by Type (2017-2022) & (USD/Unit)
Table 42. Global Gene Therapies for Tumor Treatment Price Forecast by Type (2023-2028) & (USD/Unit)
Table 43. Global Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 44. Global Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 45. Global Gene Therapies for Tumor Treatment Sales Share by Application (2017-2022)
Table 46. Global Gene Therapies for Tumor Treatment Sales Share by Application (2023-2028)
Table 47. Global Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Gene Therapies for Tumor Treatment Revenue Share by Application (2017-2022)
Table 50. Global Gene Therapies for Tumor Treatment Revenue Share by Application (2023-2028)
Table 51. Gene Therapies for Tumor Treatment Price by Application (2017-2022) & (USD/Unit)
Table 52. Global Gene Therapies for Tumor Treatment Price Forecast by Application (2023-2028) & (USD/Unit)
Table 53. North America Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 54. North America Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 55. North America Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 58. North America Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 59. North America Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Gene Therapies for Tumor Treatment Sales by Country (2017-2022) & (K Units)
Table 62. North America Gene Therapies for Tumor Treatment Sales by Country (2023-2028) & (K Units)
Table 63. North America Gene Therapies for Tumor Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Gene Therapies for Tumor Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 66. Europe Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 67. Europe Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 70. Europe Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 71. Europe Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Gene Therapies for Tumor Treatment Sales by Country (2017-2022) & (K Units)
Table 74. Europe Gene Therapies for Tumor Treatment Sales by Country (2023-2028) & (K Units)
Table 75. Europe Gene Therapies for Tumor Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Gene Therapies for Tumor Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 78. Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 79. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 82. Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 83. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2017-2022) & (K Units)
Table 86. Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2023-2028) & (K Units)
Table 87. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 90. Latin America Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 91. Latin America Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 94. Latin America Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 95. Latin America Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Gene Therapies for Tumor Treatment Sales by Country (2017-2022) & (K Units)
Table 98. Latin America Gene Therapies for Tumor Treatment Sales by Country (2023-2028) & (K Units)
Table 99. Latin America Gene Therapies for Tumor Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Gene Therapies for Tumor Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2017-2022) & (K Units)
Table 102. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2023-2028) & (K Units)
Table 103. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2017-2022) & (K Units)
Table 106. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2023-2028) & (K Units)
Table 107. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2017-2022) & (K Units)
Table 110. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2023-2028) & (K Units)
Table 111. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Major Businesses
Table 115. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. Novartis Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis Recent Development
Table 118. Kite Pharma Corporation Information
Table 119. Kite Pharma Description and Major Businesses
Table 120. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Kite Pharma Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Kite Pharma Recent Development
Table 123. Amgen Corporation Information
Table 124. Amgen Description and Major Businesses
Table 125. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Amgen Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Amgen Recent Development
Table 128. Shanghai Sunway Corporation Information
Table 129. Shanghai Sunway Description and Major Businesses
Table 130. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. Shanghai Sunway Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Shanghai Sunway Recent Development
Table 133. Sibiono Corporation Information
Table 134. Sibiono Description and Major Businesses
Table 135. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Sibiono Gene Therapies for Tumor Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sibiono Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Gene Therapies for Tumor Treatment Distributors List
Table 141. Gene Therapies for Tumor Treatment Customers List
Table 142. Gene Therapies for Tumor Treatment Market Trends
Table 143. Gene Therapies for Tumor Treatment Market Drivers
Table 144. Gene Therapies for Tumor Treatment Market Challenges
Table 145. Gene Therapies for Tumor Treatment Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapies for Tumor Treatment Product Picture
Figure 2. Global Gene Therapies for Tumor Treatment Market Share by Type in 2021 & 2028
Figure 3. Gene Induced Immunotherapy Product Picture
Figure 4. Oncolytic Virotherapy Product Picture
Figure 5. Gene Transfer Product Picture
Figure 6. Global Gene Therapies for Tumor Treatment Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Gene Therapies for Tumor Treatment Report Years Considered
Figure 11. Global Gene Therapies for Tumor Treatment Capacity, Production and Utilization (2017-2028) & (K Units)
Figure 12. Global Gene Therapies for Tumor Treatment Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Gene Therapies for Tumor Treatment Production Market Share by Region (2017-2022)
Figure 14. Global Gene Therapies for Tumor Treatment Production Market Share by Region (2023-2028)
Figure 15. Gene Therapies for Tumor Treatment Production Growth Rate in North America (2017-2028) & (K Units)
Figure 16. Gene Therapies for Tumor Treatment Production Growth Rate in Europe (2017-2028) & (K Units)
Figure 17. Gene Therapies for Tumor Treatment Production Growth Rate in China (2017-2028) & (K Units)
Figure 18. Gene Therapies for Tumor Treatment Production Growth Rate in Japan (2017-2028) & (K Units)
Figure 19. Global Gene Therapies for Tumor Treatment Sales 2017-2028 (K Units)
Figure 20. Global Gene Therapies for Tumor Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Gene Therapies for Tumor Treatment Revenue 2017-2028 (US$ Million)
Figure 22. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2017-2022)
Figure 24. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2023-2028)
Figure 25. North America Gene Therapies for Tumor Treatment Sales YoY (2017-2028) & (K Units)
Figure 26. North America Gene Therapies for Tumor Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Gene Therapies for Tumor Treatment Sales YoY (2017-2028) & (K Units)
Figure 28. Europe Gene Therapies for Tumor Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapies for Tumor Treatment Sales YoY (2017-2028) & (K Units)
Figure 30. Asia-Pacific Gene Therapies for Tumor Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Gene Therapies for Tumor Treatment Sales YoY (2017-2028) & (K Units)
Figure 32. Latin America Gene Therapies for Tumor Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Gene Therapies for Tumor Treatment Sales YoY (2017-2028) & (K Units)
Figure 34. Middle East & Africa Gene Therapies for Tumor Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Gene Therapies for Tumor Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Gene Therapies for Tumor Treatment in the World: Market Share by Gene Therapies for Tumor Treatment Revenue in 2021
Figure 37. Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 39. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 40. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 41. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 42. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 43. North America Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 44. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 45. North America Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 46. North America Gene Therapies for Tumor Treatment Sales Share by Country (2017-2028)
Figure 47. North America Gene Therapies for Tumor Treatment Revenue Share by Country (2017-2028)
Figure 48. U.S. Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 51. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 52. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 53. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 54. Europe Gene Therapies for Tumor Treatment Sales Share by Country (2017-2028)
Figure 55. Europe Gene Therapies for Tumor Treatment Revenue Share by Country (2017-2028)
Figure 56. Germany Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 57. France Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Gene Therapies for Tumor Treatment Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Gene Therapies for Tumor Treatment Revenue Share by Region (2017-2028)
Figure 67. China Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 70. India Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 72. Taiwan Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 76. Philippines Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 78. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 80. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Gene Therapies for Tumor Treatment Sales Share by Country (2017-2028)
Figure 82. Latin America Gene Therapies for Tumor Treatment Revenue Share by Country (2017-2028)
Figure 83. Mexico Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Gene Therapies for Tumor Treatment Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Share by Country (2017-2028)
Figure 92. Turkey Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 94. U.A.E Gene Therapies for Tumor Treatment Revenue (2017-2028) & (US$ Million)
Figure 95. Gene Therapies for Tumor Treatment Value Chain
Figure 96. Gene Therapies for Tumor Treatment Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
